Laboratorio Reig Jofre SA
MAD:RJF

Watchlist Manager
Laboratorio Reig Jofre SA Logo
Laboratorio Reig Jofre SA
MAD:RJF
Watchlist
Price: 2.55 EUR -0.78%
Market Cap: 204.2m EUR
Have any thoughts about
Laboratorio Reig Jofre SA?
Write Note

Relative Value

The Relative Value of one RJF stock under the Base Case scenario is 5.75 EUR. Compared to the current market price of 2.55 EUR, Laboratorio Reig Jofre SA is Undervalued by 56%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RJF Relative Value
Base Case
5.75 EUR
Undervaluation 56%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
84
Median 3Y
0.6
Median 5Y
0.8
Industry
2.5
Forward
0.6
vs History
74
vs Industry
30
Median 3Y
21.4
Median 5Y
37.5
Industry
21.8
Forward
15.4
vs History
50
vs Industry
33
Median 3Y
13
Median 5Y
14.1
Industry
16.1
vs History
30
vs Industry
12
Median 3Y
115.8
Median 5Y
21.3
Industry
23.8
vs History
50
vs Industry
59
Median 3Y
1.1
Median 5Y
1.1
Industry
2.1
vs History
77
vs Industry
84
Median 3Y
0.7
Median 5Y
0.9
Industry
2.7
Forward
0.7
vs History
76
vs Industry
83
Median 3Y
1.3
Median 5Y
1.5
Industry
5.2
vs History
76
vs Industry
43
Median 3Y
6.8
Median 5Y
8.7
Industry
13.5
Forward
6.2
vs History
82
vs Industry
33
Median 3Y
21.1
Median 5Y
25.6
Industry
16.8
Forward
16.3
vs History
50
vs Industry
31
Median 3Y
14.6
Median 5Y
16.1
Industry
15.2
vs History
vs Industry
12
Median 3Y
31.1
Median 5Y
-10.6
Industry
19.3
vs History
49
vs Industry
62
Median 3Y
0.8
Median 5Y
0.9
Industry
1.9

Multiples Across Competitors

RJF Competitors Multiples
Laboratorio Reig Jofre SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ES
Laboratorio Reig Jofre SA
MAD:RJF
204.2m EUR 0.5 17.4 5.8 13.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
755.8B USD 18.5 90.3 48.5 54.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
351.1B USD 4 23.9 11.6 15.1
US
Merck & Co Inc
NYSE:MRK
251.8B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
151.5B USD 2.5 35.6 10.6 16
P/E Multiple
Earnings Growth P/E to Growth
ES
Laboratorio Reig Jofre SA
MAD:RJF
Average P/E: 30.7
17.4
93%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
90.3
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.9
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.6
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
ES
Laboratorio Reig Jofre SA
MAD:RJF
Average EV/EBITDA: 414.2
5.8
35%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.5
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.6
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.6
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
ES
Laboratorio Reig Jofre SA
MAD:RJF
Average EV/EBIT: 1 811.5
13.8
71%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.1
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
15.1
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
16
68%
0.2

See Also

Discover More
Back to Top